Split History
ETFs Holding EKSO »    EKSO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ekso Bionics Holdings designs, develops, and markets exoskeleton products that improve human strength, endurance and mobility. Co.'s business units are EksoHealth and EksoWorks. Co.'s products in EksoHealth include: EksoNR, which is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment; and EksoUE, which is a wearable upper body exoskeleton that is used as a tool during rehabilitation. Co.'s products in EksoWorks include: EksoVest and the EVO, both of which support the weight of a worker's arms and tools, reducing the fatigue associated with working; and EksoZeroG, which is a tool holder that can mount on an aerial lift platform or scaffolding. According to our EKSO split history records, Ekso Bionics Holdings has had 1 split.
EKSO split history picture
Ekso Bionics Holdings (EKSO) has 1 split in our EKSO split history database. The split for EKSO took place on March 25, 2020. This was a 1 for 15 reverse split, meaning for each 15 shares of EKSO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.

When a company such as Ekso Bionics Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the EKSO split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ekso Bionics Holdings shares, starting with a $10,000 purchase of EKSO, presented on a split-history-adjusted basis factoring in the complete EKSO split history. EKSO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/21/2014
End date: 01/30/2023
Start price/share: $22.65
End price/share: $1.74
Dividends collected/share: $0.00
Total return: -92.32%
Average Annual Total Return: -26.88%
Starting investment: $10,000.00
Ending investment: $768.19
Years: 8.20
Date Ratio
03/25/20201 for 15
EKSO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ELGX Split History
ELOX Split History
EMMA Split History
ENSG Split History
ENVB Split History
ENZ Split History
EPRS Split History
ERNA Split History
ESMC Split History
ESRX Split History

Also explore: EKSO shares outstanding history

Email EnvelopeFree EKSO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

EKSO Insider Buying

EKSO Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.